24.10.2012 • News

Dow Cutting Jobs, Closing Plants as Growth Slows

Dow Chemical, the largest chemical maker in the United States, said on Tuesday it plans to cut 5% of its workforce and shutter 20 plants as part of a restructuring program aimed at countering a slowing global economy.

Dow and other chemical companies face slipping demand for products around the world. Rival DuPont slashed its earnings forecast and announced 1,500 job cuts.

"The reality is we are operating in a slow-growth environment in the near-term and, while these actions are difficult, they demonstrate our resolve to tightly manage operations..." Andrew Liveris, Dow's chairman and chief executive, said in a statement.

The company, which hopes to save $500 million a year, said the cuts would result in a loss of around 2,400 positions worldwide.

Among its planned plant closings, Dow will shutter a high density polyethylene facility in Belgium, a sodium borhidrate plant in the Netherlands, and a manufacturing facility in Midland, Michigan.

The company will also take an unspecified charge related to its Dow Kokam assets, reflecting weak demand for lithium-ion batteries.

Dow said it would pare capital spending and investment in programs that are no longer a priority. It said those cuts should save it an additional $500 million.

The company will take fourth-quarter charges of around 50 cents to 60 cents per share for asset impairments and write-offs, severance and other costs related to the measures.

Dow had initially planned to release its restructuring plans along with its third-quarter earnings on Thursday, but the news was inadvertently sent to a reporter at the Bloomberg News, according to a source on Dow's board of directors.

As a result, the company reported third-quarter earnings late on Tuesday and said it would hold a conference call on the results on Wednesday at 9 a.m. ET.

Dow posted a 39% fall in quarterly profit to $497 million, or 42 cents per share, hurt by weaker demand and price declines.

That compared with a profit of $815 million, or 69 cents per share in the same quarter last year, or adjusted earnings of $729 million, or 62 cents per share.

Sales were $13.6 billion, down 10% or 7% on an adjusted basis. The decline was led by Europe where sales fell 10% also hit by adverse exchange rates.

Analysts, on average, were expecting Dow to earn 37 cents a share, excluding items, on sales of $14.22 billion, according to Thomson Reuters I/B/E/S.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.